In one paragraphArticle in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Brailey BuntinDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405, USA.ORCID 0009-0004-9513-1157 Madison GuyetteDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405, USA.ORCID 0009-0006-6084-5787 Vihit GuptaDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405, USA.ORCID 0009-0008-9007-165X Kanayo IkehDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405, USA.ORCID 0000-0003-4610-3489 Sombodhi BhattacharyaDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405, USA.ORCID 0009-0004-9411-9973 Erica N LamkinSylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.ORCID 0000-0002-2404-5129 Allison LafuzeDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405, USA.ORCID 0009-0002-8952-5614 Nimrat ChatterjeeDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405, USA.ORCID 0000-0001-6556-9423 Funding
Inhibiting Rev1-mediated translesion DNA synthesis for cancer therapyR01CA279034 · NCI · DUKE UNIVERSITY · PI Jiyong Hong, Pei Zhou · 2024 to 2026
$1.6MMechanistic insights into translesion synthesis-dependent genome instabilityR35GM150992 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Nimrat Chatterjee · 2023 to 2026
$1.5MNCI NIH HHS CA279034NCI NIH HHS R01 CA279034NIGMS NIH HHS R35 GM150992NIGMS NIH HHS R35GM150992
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
G2 Phase Cell Cycle CheckpointsMitosisNuclear ProteinsNucleotidyltransferasesCyclin B1DNA DamageDNA ReplicationHumansTranslesion DNA SynthesisTubulinY-Family DNA PolymerasesCCNB1 protein, humanCyclin B1Nuclear ProteinsNucleotidyltransferasesREV1 protein, humanTubulinY-Family DNA PolymerasesCyclin B1G2/M arrestJH-RE-06REV1translesion synthesis (TLS)tubulins
Identifiers
PMID41595464
PMCPMC12841074
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390